EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of C-Reactive Protein/Albumin Ratio in Diabetic Retinopathy Patients

Şaban Kılıç iD, Emre Aydın, Çiğdem Deniz Genç iD

Diagnostics · 28.08.2025 · 15 (17) · 2178

DOI: 10.3390/diagnostics15172178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 28.08.2025. Verfasst von Şaban Kılıç und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Samsun Education and Research Hospital, Kısla, Barıs Blv. No:199, 55090 Samsun, Turkey. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to investigate the relationship between the C-reactive protein/albumin (CRP/albumin) ratio and disease severity in diabetic retinopathy (DR) patients and to evaluate the potential of CRP/albumin as a clinical biomarker for inflammation and DR progression.

Methods

This single-center, prospective, cross-sectional study included 158 DR patients and 150 healthy controls. Clinical, ophthalmologic, and laboratory evaluations were performed, including best-corrected visual acuity, optical coherence tomography, and measurements of inflammatory and glycemic markers. CRP/albumin ratios were calculated, and their relationships with DR severity were assessed. Receiver operating characteristic (ROC) analysis was performed to evaluate the predictive performance of CRP/albumin.

Results

Before treatment, CRP/Alb ratios and other inflammatory markers, including NLR, MLR, PLR, and SII, were significantly elevated in DR patients compared to controls. Following treatment, CRP/albumin ratios decreased markedly from 0.14 ± 0.1 to 0.04 ± 0.04 (p < 0.001), aligning with improvements in retinal thickness (OCT: 269.2 ± 17.5 µm) and HbA1c levels (6.9 ± 1.2%). CRP levels decreased from 5.8 ± 3.2 mg/L to 1.5 ± 1.4 mg/L, while NLR dropped from 2.5 ± 1.1 to 1.29 ± 0.8 (p < 0.001). Significant reductions were also observed in PLR (169.6 ± 62.2 to 128.2 ± 54.3) and SII (743.0 ± 427 to 230.8 ± 187). ROC analysis revealed an AUC of 0.963 for CRP/albumin, indicating high predictive accuracy for DR severity with 95% sensitivity and 90% specificity at a cutoff of 0.052.

Conclusions

The CRP/albumin ratio is a significant biomarker for inflammation and disease progression in DR. The observed reductions in inflammatory markers post-treatment highlight the importance of inflammation control in DR management.

Schlagwörter

Stichwörter der Autor:innen

CRP/albumin ratiodiabetic retinopathydisease severityglycemic controlinflammation biomarkers

Autor:innen und Institutionen

  • Department of Ophthalmology, Samsun Education and Research Hospital, Kısla, Barıs Blv. No:199, 55090 Samsun, Turkey.

ORCID-Profile: Şaban Kılıç, Çiğdem Deniz Genç

Zitieren

APA

Kılıç, Ş., Aydın, E., & Genç, Ç. D. (2025). Evaluation of C-Reactive Protein/Albumin Ratio in Diabetic Retinopathy Patients. Diagnostics, 15(17), 2178. https://doi.org/10.3390/diagnostics15172178

Vancouver

Kılıç Ş, Aydın E, Genç ÇD. Evaluation of C-Reactive Protein/Albumin Ratio in Diabetic Retinopathy Patients. Diagnostics. 2025;15(17):2178. doi:10.3390/diagnostics15172178

BibTeX
@article{Kl2025,
  author = {Kılıç, Şaban and Aydın, Emre and Genç, Çiğdem Deniz},
  title = {Evaluation of C-Reactive Protein/Albumin Ratio in Diabetic Retinopathy Patients},
  journal = {Diagnostics},
  year = {2025},
  volume = {15},
  number = {17},
  pages = {2178},
  doi = {10.3390/diagnostics15172178}
}
Kostenlos starten →